Skip to Content

Effectiveness of Inhaled COVID-19 Vaccines to Be Studied

MONDAY, Sept. 14, 2020 -- A study to assess the effectiveness of two experimental COVID-19 vaccines when they are inhaled, rather than injected, has been announced by researchers.

The trial will test the responses of 30 people, ages 18 to 55 years, when they inhale vaccine droplets in their mouths, which would directly target their respiratory systems, explained the scientists at Imperial College London and Oxford University in the United Kingdom, the Associated Press reported.

"We have evidence that delivering influenza vaccines via a nasal spray can protect people against flu as well as help to reduce the transmission of the disease," and this might also be the case with the new coronavirus, research leader Chris Chiu, Ph.D., of Imperial College London, said in a statement.

Clinical trials of the vaccines' effectiveness when injected are already underway. "It is critical we explore whether targeting the airways directly can provide an effective response compared to a vaccine injected into muscle," according to Chiu, the AP reported.

AP News Article

© 2021 HealthDay. All rights reserved.

Read this next

Despite Reopening, Britain Sees Six Straight Days of Declines in COVID-19 Cases

TUESDAY, July 27, 2021 -- COVID-19 cases in Britain have fallen for six days in a row, even though the government lifted all but a few social-distancing restrictions last...

Pfizer, Moderna to Expand Vaccine Studies in Young Children

TUESDAY, July 27, 2021 -- Pfizer and Moderna are expanding trials of their COVID-19 vaccines in children ages 5 to 11 years to more closely measure the risk for heart inflammation...

Federal, State Agencies Begin to Mandate COVID-19 Vaccines for Workers

TUESDAY, July 27, 2021 -- In a sign that the United States has reached a "tipping point" in its campaign to vaccinate Americans, California and New York City announced vaccine or...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.